Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bioventus Inc.

7.82
+0.04000.51%
Post-market: 7.820.00000.00%19:36 EDT
Volume:323.59K
Turnover:2.52M
Market Cap:517.35M
PE:-15.05
High:7.88
Open:7.74
Low:7.59
Close:7.78
Loading ...
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Jun 17, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 17, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 10, 2023

Major Issues Report

Form 8-K - Current report
May 26, 2023

Major Issues Report

Form 8-K - Current report
May 25, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 16, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Major Issues Report

Form 8-K - Current report
May 16, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Major Issues Report

8-K - Current report
Apr 18, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 11, 2023

Major Issues Report

8-K/A [Amend] - Current report
Apr 05, 2023

Major Issues Report

8-K - Current report
Mar 31, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 31, 2023

Major Issues Report

8-K - Current report
Mar 03, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals